Such antibodies may be provided in pharmaceutically acceptable compositions as known in the art or as described herein. [0963] A summary of the ways in which the antibodies of the present invention may be used therapeutically includes binding polynucleotides or polypeptides of the present invention locally or systemically in the body or by direct cytotoxicity of the antibody, e.g. as mediated by c